Weight loss drugs don’t increase risk of pancreatitis, adverse cardiac events in patients with high triglycerides: Study

In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by patients who have high triglycerides do not increase their risk of pancreatitis or adverse cardiac events.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup